3SBIO Investments

3SBIO has invested in 5 companies and its latest investment was C-Ray Therapeutics on Nov 17, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$100M
Nov 17, 2024
-
Allorion is a Massachusetts-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases.
$50M
Mar 08, 2023
-
-
May 18, 2021
-
Verseau is a Massachusetts-based biotechnology company that discovers and repolarizes macrophages for the treatment of cancer.
$50M
Oct 20, 2019
-
Refuge Biotech develops a genetic engineering platform that focuses on gene editing of immune cells for cancer immunotherapy.
$10M
May 01, 2018
-

Frequently Asked Questions about 3SBIO

  1. What is 3SBIO investing in?

    3SBIO has invested in 5 companies including C-Ray Therapeutics, Allorion and Genequantum
  2. What company did 3SBIO invest in?

    3SBIO invested in a total 5 companies including C-Ray Therapeutics, Allorion and Genequantum
  1. What are the top 5 investments by 3SBIO?

    The top companies in which 3SBIO invested are C-Ray Therapeutics, Allorion, Genequantum, Verseau and Refuge Biotechnologies, Inc.